CRH vs JNJ · P/E 20, rev $18.15B vs P/E 17, rev $49.37B
CRH PLC ADR (CRH) versus Johnson & Johnson (JNJ) — a side-by-side from cached financials, not a winner call.
CRH PLC ADR (CRH) is a building materials company listed on US.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Latest reported CRH revenue for 2026-06-30 was $18.15B. Net income was $1.31B. CRH currently screens at market cap $63.62B and trailing P/E 20.1.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
CRH currently screens at market cap $63.62B and trailing P/E 20.1. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Not investment advice. Open the CRH and JNJ stock pages for the full models.
Not investment advice.